With clinical oncology trials put on hold during the COVID-19 pandemic, researchers turned to troves of data to find patients across the country who would qualify for trials, even if they weren’t physically there. Artificial intelligence enabled this process, and may have created a move toward decentralized trials that potentially could last long after the […]
